- Home
- CHMI vs VERU Comparison
CHMI vs VERU Comparison
Compare CHMI & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMI
- VERU
- Stock Information
- Founded
- CHMI 2012
- VERU 1971
- Country
- CHMI United States
- VERU United States
- Employees
- CHMI N/A
- VERU N/A
- Industry
- CHMI Real Estate Investment Trusts
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- CHMI Real Estate
- VERU Health Care
- Exchange
- CHMI Nasdaq
- VERU Nasdaq
- Market Cap
- CHMI 97.0M
- VERU 94.5M
- IPO Year
- CHMI 2013
- VERU 1990
- Fundamental
- Price
- CHMI $2.96
- VERU $0.58
- Analyst Decision
- CHMI Hold
- VERU Strong Buy
- Analyst Count
- CHMI 2
- VERU 2
- Target Price
- CHMI N/A
- VERU $4.00
- AVG Volume (30 Days)
- CHMI 177.2K
- VERU 4.3M
- Earning Date
- CHMI 08-07-2025
- VERU 08-07-2025
- Dividend Yield
- CHMI 20.34%
- VERU N/A
- EPS Growth
- CHMI N/A
- VERU N/A
- EPS
- CHMI N/A
- VERU N/A
- Revenue
- CHMI $27,506,000.00
- VERU $16,886,419.00
- Revenue This Year
- CHMI N/A
- VERU N/A
- Revenue Next Year
- CHMI $54.92
- VERU N/A
- P/E Ratio
- CHMI N/A
- VERU N/A
- Revenue Growth
- CHMI 19.59
- VERU 134.43
- 52 Week Low
- CHMI $2.34
- VERU $0.45
- 52 Week High
- CHMI $3.99
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- CHMI 46.58
- VERU 52.23
- Support Level
- CHMI $2.87
- VERU $0.56
- Resistance Level
- CHMI $3.04
- VERU $0.74
- Average True Range (ATR)
- CHMI 0.05
- VERU 0.05
- MACD
- CHMI -0.01
- VERU -0.00
- Stochastic Oscillator
- CHMI 41.18
- VERU 36.26
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.